Impact of PSA testing on secondary care costs in England and Wales: estimates from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)

BACKGROUND: Screening men for prostate cancer using prostate-specific antigen (PSA) testing remains controversial. We aimed to estimate the likely budgetary impact on secondary care in England and Wales to inform screening decision makers. METHODS: The Cluster randomised triAl of PSA testing for Pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Thorn, Joanna C., Turner, Emma L., Walsh, Eleanor I., Donovan, Jenny L., Neal, David E., Hamdy, Freddie C., Martin, Richard M., Noble, Sian M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257301/
https://www.ncbi.nlm.nih.gov/pubmed/37296430
http://dx.doi.org/10.1186/s12913-023-09503-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257301/
https://www.ncbi.nlm.nih.gov/pubmed/37296430
http://dx.doi.org/10.1186/s12913-023-09503-7

Ejemplares similares